Product Information
BESIVANCE 0.6% SUSP is a brand product labeled by Bausch & Lomb Incorporated, priced at $44.0931 per ML under NDC 24208044605. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
6 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208044605
Classification
Brand
Dosage Form
SUSPENSION
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
BESIFLOXACINApproval Type
New Drug (NDA)
FDA Application
NDA022308On Market Since
5/28/2009
Pharmacological Classes
Price Statistics
The NADAC for BESIVANCE 0.6% SUSP has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 111.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $44.0931 per ML |
|---|---|
| All-time high | $44.2266 (Oct 15, 2025) |
| All-time low | $20.8191 (Nov 28, 2013) |
| 52-week high | $44.2266 |
| 52-week low | $44.0891 |
| Median price | $34.4471 |
| Average price | $34.0478 |
| Largest weekly change | +10.0% (Jan 14, 2015) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Besifloxacin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BESIVANCE 0.6% SUSP?
The current National Average Drug Acquisition Cost (NADAC) for BESIVANCE 0.6% SUSP, manufactured by Bausch & Lomb Incorporated, is $44.0931 per ML (NDC 24208044605), effective Jun 24, 2026.
How has the price of BESIVANCE 0.6% SUSP changed over time?
Over the history we have for it, the NADAC for BESIVANCE 0.6% SUSP has risen 111.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BESIVANCE 0.6% SUSP?
Since Nov 28, 2013, the NADAC for BESIVANCE 0.6% SUSP has ranged from a low of $20.8191 (Nov 28, 2013) to a high of $44.2266 (Oct 15, 2025), with a median of $34.4471 per ML.
Are there cheaper alternatives to BESIVANCE 0.6% SUSP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BESIVANCE 0.6% SUSP, so no direct lower-cost alternative is listed.
Who manufactures BESIVANCE 0.6% SUSP?
BESIVANCE 0.6% SUSP (NDC 24208044605) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.
Related Drugs
Same classification